Phase 3 Colon Cancer Clinical Trials

20 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–20 of 20 trials

Recruiting
Phase 3

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Metastatic Colon CancerStage III Colon Cancer
Massachusetts General Hospital400 enrolled3 locationsNCT03803553
Recruiting
Phase 2Phase 3

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer
NRG Oncology1,912 enrolled1054 locationsNCT05174169
Recruiting
Phase 3

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

MSI-H/dMMR Colorectal CancerResectable Colon Cancer
Akeso386 enrolled1 locationNCT07412613
Recruiting
Phase 2Phase 3

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Colon Cancer Stage III
Chungnam National University Hospital308 enrolled1 locationNCT05179889
Recruiting
Phase 3

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

Colon Cancer
University Hospital, Rouen232 enrolled28 locationsNCT06107920
Recruiting
Phase 3

A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer

Colon Cancer
Qilu Pharmaceutical Co., Ltd.363 enrolled1 locationNCT06686576
Recruiting
Phase 2Phase 3

Colon Cancer Diagnosis With FAPI-PET Imaging

Colon Cancer
Turku University Hospital100 enrolled1 locationNCT07272772
Recruiting
Phase 3

Endoscopic Therapy Or Surgery for Early Colon Cancer

Colon Cancer
Norwegian Department of Health and Social Affairs434 enrolled1 locationNCT06940947
Recruiting
Phase 3

The Sagittarius Trial

Colon Cancer Stage IIIColon Cancer Stage II
IFOM ETS - The AIRC Institute of Molecular Oncology700 enrolled26 locationsNCT06490536
Recruiting
Phase 3

Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More

Colon Cancer
Centre Hospitalier Universitaire Dijon150 enrolled1 locationNCT06293625
Recruiting
Phase 3

Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer

Colon Cancer
Jiangsu Famous Medical Technology Co., Ltd.730 enrolled1 locationNCT05709249
Recruiting
Phase 3

Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)

Colon Cancer
Seoul National University Hospital236 enrolled3 locationsNCT05534087
Recruiting
Phase 3

ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

Colon CancerColon Cancer (Stage II &Amp;Amp;Amp; III)
Zhejiang Cancer Hospital312 enrolled1 locationNCT06609551
Recruiting
Phase 3

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Colon Cancer Stage IIIColon Cancer Stage II
Sun Yat-sen University840 enrolled1 locationNCT05194878
Recruiting
Phase 3

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

Patients With Resected Stage II Colon Cancer
Centre Hospitalier Universitaire Dijon1,980 enrolled1 locationNCT04120701
Recruiting
Phase 3

Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

Colon Cancer Stage II
Technische Universität Dresden4,812 enrolled1 locationNCT04089631
Recruiting
Phase 3

Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer

Locally Advanced Colon Cancer
Fudan University1,370 enrolled1 locationNCT03125980
Completed
Phase 3

Short Course Oncology Therapy. A study of adjuvant chemotherapy in colorectal cancer.

Colon Cancer
Australasian Gastrointestinal Trials Group (AGITG)213 enrolled1 locationACTRN12609000662268
Active
Phase 3

ALCCaS

Colon Cancer
Philip Bagshaw600 enrolled1 locationACTRN12605000103662
Completed
Phase 3

Cetuximab and Best Supportive Care Compared with Best Supportive Care Alone in Treating Patients with Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer.

Colorectal Cancer - stage IV colon cancer - recurrent colon cancer - recurrent rectal cancer - stage IV rectal cancer
National Cancer Institute of Canada500 enrolled1 locationACTRN12606000112561